Objective To evaluate the effect of different doses of Wuzhi capsules on the pharmacokinatics of Tacrolimus in healthy human body. Methods 40 healthy volunteers were divided into 5 groups, and 0, 1, 2, 6, 8 capsules of Wuzhi capsules were given to each group accordingly after 2 mg of tacrolimus was given systematically. Venous blood was collected before and at different time points after drug administration. Blood samples were collected in anti-coagulation tubes and stored till analysis. Results The dose of tacrolimus was increased with the increase of the dose of Wuzhi capsules AUC0→t, Tmax, and the largest were (459.3±114.2)ng·h/ml and(3.125±1.356)h, respectively, and Cmax was the largest after taking two capsules (43.539±10.656) ng/ml. The CL/F ratio decreased from 51.67% to 27.09% when the dose of Wuzhi capsules increased from 1 capsule to 8 capsules. Conclusions The metabolic rate of tacrolimus decreases, the clearance rate decreases and the blood concentration increases when Wuzhi capsules are administered together with tacrolimus.
Key words
Tacrolimus /
Wuzhi capsules /
pharmacokinetics /
HPLC
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1]陈 超,邬义强,林述龙.五酯胶囊联合西药治疗慢性乙型肝炎42例疗效观察[J].云南中医中药杂志,2008, 29(11):23-24.
[2] Anglicheau D, Legendre C, Beanne P, et al. Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update[J].Pharmacogenomics,2007,8(7):835-849.
[3] MacPhee I A, Holt D W. A. pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype [J]. Transplantation, 2008, 85(2):163-165.
[4] 刘丽娟,赖雁威,李慧云,等. 肝移植患者他克莫司谷血药浓度监测意义和临床个体化用药调节[J]. 现代生物医学进展,2015,25(12):1026-1030.
[5] Park J Y, Shin H K,Choi Y W,et al. Gomisin A induces Ca2+-dependent activation of eNOS in human coronary artery endothelial cells [J]. J Ethnopharmaco1, 2009, 125(2):291-296.
[6] 徐艳霞.中草药对肝细胞色素P450的作用[J].中国药理通讯,2005,22(3):64-68.